A Multicenter, Randomized, Open Label, Single- and Multiple-Dose, Dose Finding Study and Open-Label Extension to Assess the Effects of Obeticholic Acid in Pediatric Subjects with Biliary Atresia

Trial Profile

A Multicenter, Randomized, Open Label, Single- and Multiple-Dose, Dose Finding Study and Open-Label Extension to Assess the Effects of Obeticholic Acid in Pediatric Subjects with Biliary Atresia

Recruiting
Phase of Trial: Phase II

Latest Information Update: 02 Jun 2017

At a glance

  • Drugs Obeticholic acid (Primary)
  • Indications Biliary atresia
  • Focus Adverse reactions; Pharmacokinetics
  • Acronyms CARE
  • Sponsors Intercept Pharmaceuticals
  • Most Recent Events

    • 17 Apr 2016 Trial design presented at The International Liver Congress™ 2016
    • 30 Mar 2016 According to Intercept media release, will be presented at the International Liver Congress 2016, the 51st Annual Meeting of the European Association for the Study of the Liver (EASL).
    • 21 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top